IAVI

KAVI-Institute of Clinical Research (KAVI-ICR) was awarded the 2022 International AIDS Vaccine Initiative (IAVI) External Quality Assessment (EQA) Awards For Tier 1 and Tier 2. This is the second year running that the Institute has won this prestigious award. It recognises the best performing laboratories amongst their Clinical Research Centres in Africa. The Institute at the University of Nairobi, KNH Campus was first among Tier 1 and the Kangemi site among Tier 2.

Over three days September 14th-16th, 2022, ADVANCE partners, USAID, International AIDS Vaccine Initiative, and program Principal Investigators shared relevant presentations and participated in rich discussions reviewing program progress, challenges, and opportunities to maximize success for HIV biomedical prevention technologies and capacity strengthening across the all the partners' network in Kigali, Rwanda.

Dr. Omosa, a lecturer in the Department of Medical Microbiology and Clinical Researcher, KAVI – ICR, UoN has been awarded a grant by IAVI to establish a scientific manuscript writing program at the College of Health Sciences, University of Nairobi.